These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 364713)

  • 21. Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. I. Synergism between BCG and line 10 tumor cells in the induction of an inflammatory response.
    Key ME; Hanna MG
    J Natl Cancer Inst; 1981 Oct; 67(4):853-61. PubMed ID: 6944552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. II. Influence of the local inflammatory response on immune reactivity.
    Key ME; Hanna MG
    J Natl Cancer Inst; 1981 Oct; 67(4):863-9. PubMed ID: 6944553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Different pathogenic power of the original BCG strain of the Pasteur Institute and of an isoniazid resistant strain. Histopathological study and significance of local abscesses after inoculation of guinea pig].
    Levaditi JC; Baloquet G; Kosloff-Senechal ; Augier J; Augier S; Baret M
    Sem Hop; 1975 Apr; 51(17):1167-73. PubMed ID: 174202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of Mycobacterium bovis BCG-Praha on the growth of Daels' guinea-pig sarcoma (author's transl)].
    Schwartz E
    Zentralbl Bakteriol Orig A; 1974 Jun; 226(4):497-509. PubMed ID: 4152732
    [No Abstract]   [Full Text] [Related]  

  • 25. Mechanism of BCG induced regression of line 10 hepatocarcinoma in the guinea pig.
    Steerenberg PA; De Jong WH; Ruitenberg EJ
    In Vivo; 1991; 5(6):655-61. PubMed ID: 1810452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Shared antigens between BCG and tumor cells--immunotherapy with BCG for mouse tumor].
    Sasaki J; Kanda S; Sawamura D; Kamiya S; Inaba Y; Kawashima M
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1432-9. PubMed ID: 4015119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy.
    Mathé G; Halle-Pannenko O; Bourut C
    Natl Cancer Inst Monogr; 1973 Dec; 39():107-13. PubMed ID: 4150738
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparison of protective effect of killed and live BCG bacilli and INH-resistant tubercle bacilli in guinea pigs].
    Paklerska-Pobratyn H; Kostrzeński W
    Gruzlica; 1968 Jun; 36(6):509-16. PubMed ID: 4970098
    [No Abstract]   [Full Text] [Related]  

  • 29. A 64 kDa protein from Mycobacterium bovis BCG shares the same antigenic determinants with line 10 hepatoma cells and has anti-line 10 tumor activity.
    Ahsan CR; Sasaki J
    FEBS Lett; 1991 Aug; 288(1-2):77-80. PubMed ID: 1715293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Mycobacterium bovis BCG-Praha on the growth of transplanted Daels' sarcoma in guinea-pigs.
    Schwartz E
    Neoplasma; 1973; 20(4):375-86. PubMed ID: 4580793
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunotherapy by BCG against prostate adenocarcinomas in anatomical compartments.
    Pollard M; Luckert PH
    Anticancer Res; 1994; 14(6B):2691-4. PubMed ID: 7872703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of living BCG or BCG cell walls (CW) in the treatment of guinea pig hepatoma.
    Zbar B; Hunter J; Rapp HJ; Canti G
    Cancer; 1979 Feb; 43(2):484-91. PubMed ID: 421175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of the line-10 guinea pig hepatocarcinoma by antigens related to both Mycobacterium bovis (BCG) and the tumor.
    Minden P; Mathews HL; Kelleher PJ
    J Immunol; 1980 Dec; 125(6):2685-9. PubMed ID: 7000904
    [No Abstract]   [Full Text] [Related]  

  • 34. Eradication by immunization with mycobacterial vaccines and tumor cells of microscopic metastases remaining after surgery.
    Zbar B; Canti G; Ashley MP; Rapp HJ; Hunter JT; Ribi E
    Cancer Res; 1979 May; 39(5):1597-603. PubMed ID: 427799
    [No Abstract]   [Full Text] [Related]  

  • 35. [Virulence of BCG and induction of cellular immunity (2)].
    Miura K; Takahashi H; Murohashi T; Hashimoto T
    Nihon Saikingaku Zasshi; 1975 Jan; 30(1):255. PubMed ID: 765561
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of Myobacterium bovis (strain Bacillus Calmette-Guérin) on macrophage production by the bone marrow of tumor-bearing mice.
    Fisher B; Taylor S; Levine M; Saffer E; Fisher ER
    Cancer Res; 1974 Jul; 34(7):1668-70. PubMed ID: 4599359
    [No Abstract]   [Full Text] [Related]  

  • 37. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
    de Lisle GW; Wards BJ; Buddle BM; Collins DM
    Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy of a guinea pig hepatoma with mycobacterial vaccines: comparison of BCG cell walls and cell wall skeletons.
    Yarkoni E; Rapp HJ
    Infect Immun; 1978 Sep; 21(3):1029-32. PubMed ID: 361572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L2C leukemia: a model of human acute leukemia.
    Murphy SG; LoBuglio AF
    Fed Proc; 1977 Aug; 36(9):2281-5. PubMed ID: 328309
    [No Abstract]   [Full Text] [Related]  

  • 40. BCG-RIVM: a new BCG preparation for intravesical immunotherapy of superficial bladder cancer.
    Schreinemachers L; Van der Meyden A; Steerenberg P; Feitz W; Groothuis D; De Jong W; Debruyne F
    Chemioterapia; 1987 Jun; 6(2 Suppl):713-6. PubMed ID: 3334665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.